MedCity News » medical devices

FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy. The post FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes appeared first on MedCity News.

Feb 9, 2025 - 22:03
 0
FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

The post FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes appeared first on MedCity News.

Read More

Tags:

Previous Article

How Medicare Coverage Diversifies Access to Innovation

Next Article

Here’s a Preview of the Startups Pitching in the Medical Device Track at MedCity...

Related Posts

Marketing’s Untapped Opportunity in the Medical Product Lifecycle

Marketing’s Untapped Opportunity in the Medical Product...

Mar 26, 2025  0

The Future of Robotic Surgery: Leading the Way with Digital Solutions

The Future of Robotic Surgery: Leading the Way with Dig...

Feb 9, 2025  0

Wearable Health Tech: Innovations and Impacts on Chronic Disease Management

Wearable Health Tech: Innovations and Impacts on Chroni...

Feb 9, 2025  0